Navigation Links
Best Practice Database Adds Research on Merger Integration and Competitive Intelligence
Date:5/20/2008

CHAPEL HILL, N.C., May 20 /PRNewswire/ -- New research that delivers insights into merger and acquisition integration and competitive intelligence data gathering for the pharma industry is now available in the Best Practice Database, an online research repository managed by research and consulting firm Best Practices, LLC.

To review sample key findings and key metrics in these studies, go to a landing page with links to each study at this address: http://www3.best-in-class.com/dr305.htm .

The Database is an online resource containing more than $30 million in proprietary research conducted on behalf of executives from Fortune 500 companies. You can use this tool to quickly locate studies that identify best practices and metrics in the areas most important to you and your company.

Research added this month to the Best Practice Database includes a benchmarking study on the key success factors in the merger & acquisition integration process for pharmaceutical and biotechnology companies. Experienced integration champions noted that often the structure for managing an acquired asset will change over a 12-36 month period. Cost reduction, milestone progress, and performance above or below expected performance targets are key drivers of structure change, according to the study.

Also new to the Database this month are studies that explore how organizations can optimize their competitive intelligence operations while working within defined guidelines and the changing landscape of safety and risk management for the pharma industry.

The new research is available in these Best Practice Database Documents (with ID Number):

-- M&A Integration Excellence: What Bio-Pharma Companies Need to Know

(4997)

-- Safety and Risk Management in the Pharmaceutical Sector (4998)

-- Pharmaceutical Competitive Intelligence Excellence: Optimizing Data

Collection within Approved Guidelines (4999)

To view these studies or other studies in the Database, sign up for our complimentary weekly tour, held on Thursdays at 11 a.m. EDT (GMT-5). To sign up, go to this address: http://www3.best-in-class.com/dw212.htm . If you prefer a different time, simply indicate your preference on the sign up form.

To review abstracts and other information about these studies, go to a landing page with links to each study at this address: http://www3.best-in-class.com/dr305.htm .

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, a pharmaceutical research and consulting firm, conducts work based on the principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class organizations. For more information, call 919-403-0251 or visit http://www.best-in-class.com/ .


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Best Practices Insurance Services Announces Key Additions to Senior Management
2. Fortune 500s to Convene in Florida, Sharing Insights & Best Practices for Developing Tomorrows Leaders
3. Global Pharmaceutical Launches: Best Practices for Winning Product Launch Successes
4. The 2008 AMIA Spring Congress to Showcase Best Practices and Innovations in Biomedical and Health Informatics Research and Education
5. New Employment Practices Liability Policy from Beazley Offers Major Additional Benefits
6. Discover Talent Management Best Practices June 4-6 -- Registration Ends Friday
7. 1 of the best researchers in general practice
8. Hudson Valley Fertility Opens First Advanced Fertility Practice in the Hudson Valley
9. Three-Day Strike by Hundreds of Security Officers at Kaiser Hospitals Succeeds in Raising Red Flag About Unfair Labor Practices
10. ACP says Medicare cuts will hurt physicians in small practices
11. Best Practice Database: Complimentary Excerpt of Three Sales Force Excellence Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... The Golseth Agency, a Texas based insurance ... is spearheading a regional charity campaign organized to provide support to Christina Upchurch and ... this year, Christina and her children returned from out of town to find her ...
(Date:8/18/2017)... Raton, Fl (PRWEB) , ... August 18, 2017 ... ... largest network of highly trained practitioners specializing in bioidentical hormone replacement therapy and ... associated with hormone imbalance and conditions of aging, such as menopause, andropause, thyroid ...
(Date:8/18/2017)... ... ... Alcovit, a lime-flavored beverage that rids the body of toxins linked to ... available through Jet.com. , After 25 years of development, the company released its ... quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun with friends ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... and call tracking and monitoring solutions, announced today the launch of a redesigned ... a modern navigation and aesthetic, fully responsive design, and an enhanced search directory ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Dangerous Inheritance”: a mystery about saving the family ... is from Southwest Nebraska where she was raised on a farm. As Diane ... is fictional, but the friendships and mantra of ‘neighbors helping neighbors’ have always been ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017  Axium Pharmaceuticals Inc., the creator of ... to be in the beginning stages of an IPO. ... epilepsy medications with the average cost of a prescription epilepsy drug being ... AXIUM ... Another staggering figure is the fact that ...
(Date:8/14/2017)... TIKVAH, Israel , Aug. 15, 2017 ... developer of adult stem cell technologies for neurodegenerative diseases, ... 30, 2017. "We ... pivotal Phase 3 trial to investigate NurOwn ® ... Chief Executive Officer of BrainStorm. "We have agreements with ...
(Date:8/8/2017)... 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... its financial results for the second quarter ended June ... second quarter 2017 and to date: ... programs for the Company,s lead project, BL-8040: ... with BL-8040 as novel stem cell mobilization treatment for ...
Breaking Medicine Technology: